Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study-Reference-Cited by-同舟云学术

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

Published:2010-04-02 Issue:1 Volume:122 Page:169-176
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Alba Emilio,Ruiz-Borrego Manuel,Margelí Mireia,Rodríguez-Lescure Álvaro,Sánchez-Rovira Pedro,Ruiz Amparo,Mel-Lorenzo Jose Ramón,Ramos-Vázquez Manuel,Ribelles Nuria,Calvo Elisa,Casado Antonio,Márquez Antonia,Vicente David,García-Sáenz José Angel,Martín Miguel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0860-9.pdf

Reference20 articles.

1. Mouridsen HT (1992) Systemic therapy of advanced breast cancer. Drugs 44(Suppl 4):17–28

2. Coates AS, Byrne M, Bishop JF et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer. Intermittent versus continuous chemotherapy for breast cancer. N Engl J Med 317:1490–1495

3. Harris AL, Cantwell BM, Carmichael J et al (1990) Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet 335:186–190

4. Muss HB, Case LD, Richards F II et al (1991) Interrupted versus continuous chemotherapy in patients with metastatic breast cancer: the Piedmont Oncology Association. N Engl J Med 325:1342–1348

5. Ejlertsen B, Pfeiffer P, Pedersen D et al (1993) Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months. Eur J Cancer 29A:527–531

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study;Cancer Research and Treatment;2022-10-15

2. The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study;Annals of Translational Medicine;2022-09

3. Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data;Therapeutic Advances in Drug Safety;2022-01

4. The prognosis of cancer patients undergoing liposomal doxorubicin-based chemotherapy;Medicine;2021-08-27

5. The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine;Translational Cancer Research;2021-03